Using Next-generation Sequencing to Bring Routine Genetic Testing into Cancer MedicineWednesday, 16 October 2013 at 09:00 Add to Calendar ▼SELECTBIOenquiries@selectbiosciences.com Next-generation sequencing offers the potential to revolutionise clinical diagnostics. This is particularly true in cancer; nearly 100 cancer predisposition genes with clinical utility are recognised, but clinical testing for the majority is not available or is very restricted. The Mainstreaming Cancer Genetics Programme (www.mcgprogramme.com) is seeking to address this, and a primary projective is the development of an NGS panel that can consistently and robustly identify genetic variants of relevance to cancer. |